Campbell & CO Investment Adviser LLC Royalty Pharma PLC Transaction History
Campbell & CO Investment Adviser LLC
- $1.27 Billion
- Q1 2025
A detailed history of Campbell & CO Investment Adviser LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 50,900 shares of RPRX stock, worth $1.69 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
50,900
Previous 95,220
46.54%
Holding current value
$1.69 Million
Previous $2.43 Million
34.79%
% of portfolio
0.12%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.37 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$766 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$446 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$405 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...